Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Corticosteroids, systemic (oral, parenteral)

5

XVII.g Tuberculosis (pulmonary, pulmonary, extrapulmonary or disseminated). Reactivation or de novo

3
Last update : 30/12/2013
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Adrenocorticotropic hormone (ACTH)
2
Budesonide (p.o.)
1
Corticosteroids, inhaled (ICS)
5
Methylprednisolone
2
Prednisone
5
Salt (NaCl)
1

Publications

Risk of tuberculosis comparison in new users of antitumour necrosis factor-α and with existing disease-modifying antirheumatic drug therapy.
Journal of clinical pharmacy and therapeutics 2018 Apr;43;256-264 2018 Apr
Ileocolonic tuberculosis clinically, endoscopically, and radiologically mimicking Crohn's disease: disseminated infection after treatment with infliximab.
Journal of Crohn's & colitis 2014 Jun;8;560-2 2014 Jun
Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases.
American journal of respiratory and critical care medicine 2011 Mar 01;183;675-8 2011 Mar 01
Mycobacterium tuberculosis infection in patients with systemic rheumatic diseases. A case-series.
Clinical and experimental rheumatology 1999;17;289-96 1999
Tuberculosis in ulcerative colitis: bird in the bush.
Tropical gastroenterology : official journal of the Digestive Diseases Foundation 1994;15;219-21 1994

Powered by

  • ^
  • Contact
  • Cookies
  • About